Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance

Isabel Sala1, María Belén Sánchez-Saudinós, Laura Molina-Porcel

  • 1Memory Disorders Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Insights

Elevated total plasma homocysteine (tHcy) did not differentiate dementia diagnoses. However, higher tHcy levels were linked to poorer performance in visual-spatial tasks, suggesting a negative impact on visuoconstructional abilities.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Gerontology

Background:

  • Elevated total plasma homocysteine (tHcy) is a known risk factor for cardiovascular and cerebrovascular diseases.
  • tHcy has been proposed as a potential risk factor for dementia and Alzheimer's disease (AD).
  • The precise relationship between tHcy levels and cognitive impairment remains unclear.

Purpose of the Study:

  • To investigate the association between tHcy levels and clinical diagnoses of cognitive impairment.
  • To determine the relationship between tHcy levels and cognitive performance in outpatients with cognitive decline.

Main Methods:

  • Assessed plasma tHcy, folate, vitamin B12, and creatinine levels in outpatients.
  • Included diagnostic groups: subjective memory complaints (SMC), mild cognitive impairment (MCI), Alzheimer's disease (AD), and vascular dementia (VD).
  • Conducted comprehensive neuropsychological testing covering attention, memory, language, executive functions, and daily living activities.

Main Results:

  • No significant differences in tHcy levels were observed across diagnostic groups (SMC, MCI, AD, VD).
  • Increased tHcy levels correlated with diminished performance on the geometric figure copy and clock drawing tests.
  • Elevated tHcy did not distinguish between different diagnostic categories of cognitive impairment.

Conclusions:

  • tHcy levels are not effective in discriminating between diagnostic groups of cognitive impairment.
  • Elevated tHcy levels in patients with cognitive impairment appear to negatively impact visuoconstructional performance.
  • Further research is needed to elucidate the role of tHcy in the progression of cognitive decline.
Abstract

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Language and Cognition01:27

Language and Cognition

Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...